Eli Lilly (LLY)

• Market cap: $818B
• 1 day: 1.47%
• 5 days: 0.25%
• 1 month: -10.94%
• 3 months: -14.98%
• 6 months: 28.23%
• Year to date: -15.18%
• 1 year: 7.5%
• 5 years: 400.47%
• 10 years: 1,197.52%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 50,000